Tech titans show sign of fatigue with spike in buying climaxes

The Nasdaq 100 (NDX) is hitting new highs, but options traders are pricing in more volatility as we enter earnings season, with the NDX's version of the "fear gauge" (the VXN) rising in recent days. Entering Monday afternoon, the NDX was up more than 1%, and the VXN was up by more than 8%. That had never happened before.

It's also odd that even while the Nasdaq Composite was setting record highs, momentum in breadth underlying that market has been poor. The McClellan Oscillator for the Nasdaq was below -25 even as the index was setting new highs earlier this week. 

This is a little more troubling given Monday's rejection of a record high in the bigger tech stocks. The Nasdaq 100 rallied more than 2% to an all-time high, only to reverse and close down by more than 1%. The only other day when that happened was March 7, 2000. Looking at smaller reversals, the tone over the next 2-3 months was still generally negative. 

The reversal in the Nasdaq 100 coincided with the 2nd-largest number of buying climaxes in those stocks as well. Only early 2018 had more. 

Nasdaq 100 tech stock buying climaxes

The run in these stocks has been historic, and the momentum in many stocks underlying the move in the indexes is waning. Combined with reversals in some of them as we saw on Monday, it's a yellow flag.

This is an abridged version of our recent reports and notes. For immediate access with no obligation, sign up for a 30-day free trial now.

We also looked at:

  • A more in-depth look at the Nasdaq 100 versus the VXN and McClellan Oscillator
  • Late last week, every energy stock was below every moving average
  • Optimism on the U.S. dollar just fell to its lowest in years, but that doesn't mean what you might think
  • Despite a huge gain in stocks, Risk Appetite is subdued

The post titled Tech titans show sign of fatigue with spike in buying climaxes was originally published as on on 2020-07-15.

At, our service is not focused on market timing per se, but rather risk management. That may be a distinction without a difference, but it's how we approach the markets. We study signs that suggest it is time to raise or lower market exposure as a function of risk relative to probable reward. It is all about risk-adjusted expectations given existing evidence. Learn more about our service , research, models and indicators.

Follow us on Twitter for up to the minute analysis of market action.

Not ready to signup up for a free trial yet?

Signup for our Daily Lite email to receive highlights of our daily report, research and studies.

Follow us on Twitter:

Subscribe to our Youtube Channel:

RSS Feed

Subscribe to the Blog RSS feed